‹ All Posts
Pradeep Carpenter

3rd Jan · SEBI-Registered Analyst

Aurobindo Pharma Ltd – Technical Analysis Report

AUROPHARMA
has been consolidating in a ₹1,150–₹1,250 range for the past month, indicating base formation after a prior move. The stock is currently trading near the upper end of this range, reflecting improving bullish bias. On the daily chart, a Golden Cross is visible, with the 50-day SMA crossing above the 200-day SMA, signaling a positive medium-to-long-term trend. Price is sustaining above both moving averages, with the 50 SMA acting as a dynamic support zone. From a pattern perspective, a cup-and-handle formation is developing, with ₹1,250 as the neckline, while a falling wedge breakout further strengthens the bullish setup. The presence of multiple bullish patterns near resistance enhances breakout probability. Momentum indicators are supportive, with RSI reversing from the 45 zone and MACD crossing above the zero line, indicating a shift toward bullish momentum. Key Levels: ₹1,250 is the critical breakout resistance, ₹1,150 is immediate support, and a breakdown below ₹1,130 would negate the bullish structure. Upside Potential: A sustained breakout above ₹1,250 may lead to an upside move toward ₹1,350 initially, followed by ₹1,500+ in the medium term. Technical View: The stock is at a crucial inflection point, and a volume-backed breakout above ₹1,250 could trigger a fresh trending move, while risk remains well-defined below ₹1,130.

#Today’sTradingSetup#TechnicalViews#FundamentalViews#SectorBreakouts#EquityResearch
aurophram.JPG
1 like